A new research paper introduces MAGI, an open-source agent designed to coordinate molecular design tools for drug discovery. MAGI can either generate molecules directly using an LLM or delegate to the REINVENT 4 system. Tested on nine retrospective lead-optimization campaigns from pharmaceutical companies, MAGI produced valid structures, with LLM proposals reaching comparable or higher primary activity in fewer operations. The study found that the success of a campaign was primarily limited by the accuracy of predictive models rather than the generation route, and expert chemists could not distinguish MAGI's output from human-generated work. AI
IMPACT Positions AI agents as a viable coordination layer for computational chemistry workflows, with performance limited by predictive models.
RANK_REASON Research paper detailing a new AI agent for drug discovery. [lever_c_demoted from research: ic=1 ai=1.0]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
